🛰️ Daily AI Frontier
‹ back to 2026-08-20

Monroe: A Molecular Foundation Model for In-Context Probabilistic Inference

Research Bioinformatics AI

Ranking

Overall 76
Content 95
Popularity 31

Observed public metrics from 1 member.

Merged summary

TL;DR - Monroe is a molecular foundation model pretrained on more than 81 million molecules and paired with TabPFN for in-context bioassay activity prediction. It matches or exceeds prior models on established benchmarks and significantly improves performance on activity-cliff tasks relevant to molecular discovery.

  • Introduces richer stereochemistry-aware graph representations, conformer-denoising and embedding-decorrelation losses, and improved multi-task learning.
  • Uses a prior-data-fitted network as the downstream predictor, targeting data-scarce drug-discovery settings without conventional task-specific adaptation.
  • Applies statistically principled pairwise comparisons on Polaris and activity-cliff benchmarks.
  • The PFN strategy also improves MiniMol and CheMeleon, indicating that the downstream approach generalizes beyond Monroe.

Sources (1)

Monroe: A Molecular Foundation Model for In-Context Probabilistic Inference

arXiv cs.LG Blazej Banaszewski, Andrew W. Fitzgibbon 2026-08-19 arXiv:2608.18982
Public signals Hugging Face upvotes 0 · Semantic Scholar citations 0 · Semantic Scholar influential citations 0
Providers: Hugging Face · Upvotes 0 OpenAlex · N/A Publisher · N/A Semantic Scholar · Citations 0 · Influential citations 0 X · N/A Fetched 2026-09-19 14:26:38.637404 UTC

TL;DR - Monroe is a molecular foundation model pretrained on more than 81 million molecules and paired with TabPFN for in-context bioassay activity prediction. It matches or exceeds prior models on established benchmarks and significantly improves performance on activity-cliff tasks relevant to molecular discovery.

  • Introduces richer stereochemistry-aware graph representations, conformer-denoising and embedding-decorrelation losses, and improved multi-task learning.
  • Uses a prior-data-fitted network as the downstream predictor, targeting data-scarce drug-discovery settings without conventional task-specific adaptation.
  • Applies statistically principled pairwise comparisons on Polaris and activity-cliff benchmarks.
  • The PFN strategy also improves MiniMol and CheMeleon, indicating that the downstream approach generalizes beyond Monroe.
item →